Skip to main content

Sarcoma

We take a diligent and broad approach in some of the most challenging, but potentially most impactful areas of cancer research. This includes sarcoma, which makes up fewer than 1%1 of cancer subtypes, and people living with this condition have a high unmet need.

Latest Articles

Dan looking at horizon

A unique take on life with an ultra rare cancer

In 2018, Dan was diagnosed with a rare form of sarcoma called dedifferentiated liposarcoma. Receiving this diagnosis inspired Dan to live each day to the fullest.

Read more
Image of two family members supporting each other
Sarcoma

Dedifferentiated liposarcoma: an ultra-rare cancer

An aggressive subtype of a category of cancers called soft tissue sarcoma (STS). DDLPS has a poor prognosis and limited treatment options.
Read more

Related Content

Dr Daniel Morgensztern
Article

Sarcoma: An expert's perspective

Hear from Gary Schwartz, MD, Director of the Case Comprehensive Cancer Center, Cleveland, Ohio.
Read more
MDM2 Brightline Article
Cancer

Brightline-1 trial launch in rare sarcoma

Find out more from Mehdi Lahmar, Clinical Program Leader for Oncology, about our commitment to patients with Dedifferentiated Liposarcoma (DDLPS).
Read more
Two hands shaping some medication into a heart
Cancer

Why cancer care is personal for us

Find out more about Boehringer Ingelheim’s generational commitment to transforming cancer care.
Read more
  • [1]
    Grimer RJ, et al. Size Matters for Sarcomas! Ann R Coll Surg Engl. 2006 Oct, 88(6): 591-524.